SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-253754
Filing Date
2015-07-15
Accepted
2015-07-15 17:22:07
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5) d915432d424b5.htm 424B5 815574
2 GRAPHIC g915432g09k06.jpg GRAPHIC 51203
3 GRAPHIC g915432g27e76.jpg GRAPHIC 73717
4 GRAPHIC g915432g31a53.jpg GRAPHIC 40192
5 GRAPHIC g915432g42h18.jpg GRAPHIC 73873
6 GRAPHIC g915432g55m39.jpg GRAPHIC 33345
7 GRAPHIC g915432g60b51.jpg GRAPHIC 67167
8 GRAPHIC g915432g64l82.jpg GRAPHIC 62964
9 GRAPHIC g915432g73a92.jpg GRAPHIC 25606
10 GRAPHIC g915432g74m10.jpg GRAPHIC 36815
11 GRAPHIC g915432g75k85.jpg GRAPHIC 36180
12 GRAPHIC g915432g79n38.jpg GRAPHIC 55501
13 GRAPHIC g915432g89g88.jpg GRAPHIC 30205
14 GRAPHIC g915432g98h56.jpg GRAPHIC 39490
  Complete submission text file 0001193125-15-253754.txt   1681532
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-200006 | Film No.: 15989946
SIC: 2834 Pharmaceutical Preparations